journal article·2018

A multi-responsive biomimetic nano-complex platform for enhanced gene delivery

Xiaoyu Bai, Ming Kong, Xuanjin Wu, Chao Feng, Hyunjin Park, Xiguang Chen

Journal of Materials Chemistry B· Volume 6· Issue 37
Publisher page

Abstract

RNA interference (RNAi) is widely regarded as a promising technology for disease treatment, yet one major obstacle for its clinical application is the lack of enhanced siRNA delivery vehicles to circumvent complex extra- and intracellular barriers. By integrating unique peculiarities of thioglycolic acid conjugated chitosan nanoparticles (TCS NPs), biomimetic transfersomes (T) and amphiphilic hyaluronic acid (HA-GMS), a novel nano-complex was prepared, where vascular endothelial growth factor (VEGF) siRNA loaded TCS NPs were cloaked by transfersomes with HA-GMS assembled on the surface (HT-TCS-siRNA NPs). The nano-complex provided superior siRNA protection and desirable stability at pH 7.4 and 6.5 (mimicking tumor tissue) and exerted proton sponge effects at acidic pH 5.0 (mimicking endo/lysosomes). The TCS NPs were stable at pH 5.0 but disintegrated in the presence of 10 mM glutathione (GSH) at pH 7.4 (mimicking tumor cytosol), which was favorable to release siRNA to the cytoplasm. In vitro cell uptake and gene silencing assays exhibited enhanced intracellular siRNA accumulation and VEGF silencing efficacy of HT-TCS-siRNA NPs in HeLa cells. The enhanced gene delivery capacity of the multi-responsive biomimetic nano-complex gives them potential for application in cancer therapy.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Marine Life Science

Ocean University of China

Qingdao

P. R. China

Graduate School Biotechnology

Korea University

Seoul 136-701

South Korea

Funding

National Natural Science Foundation of China

References (45)

Show source-provided references
1. Feng · Biomaterials · 2014 · 35 · 502810.1016/j.biomaterials.2014.03.012 ↗
2. Tseng · Adv. Drug Delivery Rev. · 2009 · 61 · 72110.1016/j.addr.2009.03.003 ↗
3. Resnier · Biomaterials · 2013 · 34 · 642910.1016/j.biomaterials.2013.04.060 ↗
4. Yin · Nat. Rev. Genet. · 2014 · 15 · 54110.1038/nrg3763 ↗
5. Hickerson · J. Invest. Dermatol. · 2011 · 131 · 103710.1038/jid.2010.426 ↗
6. Nair · J. Am. Chem. Soc. · 2014 · 136 · 1695810.1021/ja505986a ↗
7. Boisguerin · Adv. Drug Delivery Rev. · 2015 · 87 · 5210.1016/j.addr.2015.02.008 ↗
8. Asai · Biochem. Biophys. Res. Commun. · 2014 · 444 · 59910.1016/j.bbrc.2014.01.107 ↗
9. Schneider · Mol. Ther.–Nucleic Acids · 2012 · 1 · e4610.1038/mtna.2012.39 ↗
10. Cuellar · Nucleic Acids Res. · 2015 · 43 · 118910.1093/nar/gku1362 ↗
11. Rosi · Science · 2006 · 312 · 102710.1126/science.1125559 ↗
12. Rozema · Proc. Natl. Acad. Sci. U. S. A. · 2007 · 104 · 1298210.1073/pnas.0703778104 ↗
13. Nuhn · Biomacromolecules · 2014 · 15 · 411110.1021/bm501148y ↗
14. Akinc · Nat. Biotechnol. · 2008 · 26 · 56110.1038/nbt1402 ↗
15. Semple · Nat. Biotechnol. · 2010 · 28 · 17210.1038/nbt.1602 ↗
16. Conwell · Mol. Ther. · 2008 · 16 · 37010.1038/sj.mt.6300356 ↗
17. Wang · J. Controlled Release · 2011 · 151 · 9510.1016/j.jconrel.2010.12.011 ↗
18. Huang · Curr. Gene Ther. · 2012 · 12 · 27510.2174/156652312802083576 ↗
19. Li · Biomaterials · 2008 · 29 · 361710.1016/j.biomaterials.2008.05.020 ↗
20. Srinivasan · Mol. Ther. · 2006 · 14 · 19210.1016/j.ymthe.2006.03.010 ↗
21. Singh · ACS Nano · 2008 · 2 · 104010.1021/nn8000565 ↗
22. Tezgel · J. Colloid Interface Sci. · 2018 · 510 · 4510.1016/j.jcis.2017.09.045 ↗
23. Van den Bossche · Biomaterials · 2011 · 32 · 308510.1016/j.biomaterials.2010.12.043 ↗
24. Ito · Cancer Lett. · 2004 · 212 · 16710.1016/j.canlet.2004.03.038 ↗
25. Tarahovsky · Biophys. J. · 2004 · 87 · 105410.1529/biophysj.104.042895 ↗
26. El Zaafarany · Int. J. Pharm. · 2010 · 397 · 16410.1016/j.ijpharm.2010.06.034 ↗
27. Chan · Biomaterials · 2012 · 33 · 492810.1016/j.biomaterials.2012.03.038 ↗
28. Kong · Carbohydr. Polym. · 2017 · 169 · 34110.1016/j.carbpol.2017.03.090 ↗
29. Chen · ACS Appl. Mater. Interfaces · 2016 · 8 · 2245710.1021/acsami.6b05041 ↗
30. Wang · Acta Biomater. · 2015 · 23 · 13610.1016/j.actbio.2015.05.028 ↗
31. Zuo · Int. J. Biol. Macromol. · 2017 · 104 · 15710.1016/j.ijbiomac.2017.06.020 ↗
32. Zhao · Carbohydr. Polym. · 2016 · 136 · 30710.1016/j.carbpol.2015.09.049 ↗
33. Kong · Chem. Commun. · 2015 · 51 · 145310.1039/C4CC08746A ↗
34. Hu · Proc. Natl. Acad. Sci. U. S. A. · 2011 · 108 · 1098010.1073/pnas.1106634108 ↗
35. Fang · Nano Lett. · 2014 · 14 · 218110.1021/nl500618u ↗
36. Malmo · J. Controlled Release · 2012 · 158 · 26110.1016/j.jconrel.2011.11.012 ↗
37. Yang · ACS Appl. Mater. Interfaces · 2017 · 9 · 1220310.1021/acsami.6b16556 ↗
38. Liu · Biomaterials · 2007 · 28 · 128010.1016/j.biomaterials.2006.11.004 ↗
39. de Fougerolles · Nat. Rev. Drug Discovery · 2007 · 6 · 44310.1038/nrd2310 ↗
40. Park · Biomaterials · 2010 · 31 · 525810.1016/j.biomaterials.2010.03.018 ↗
41. Mellman · Annu. Rev. Cell Dev. Biol. · 1996 · 12 · 57510.1146/annurev.cellbio.12.1.575 ↗
42. Huotari · EMBO J. · 2011 · 30 · 348110.1038/emboj.2011.286 ↗
43. Khalil · Pharmacol. Rev. · 2006 · 58 · 3210.1124/pr.58.1.8 ↗
44. Yoon · Biomaterials · 2012 · 33 · 398010.1016/j.biomaterials.2012.02.016 ↗
45. Hadj-Slimane · Biochimie · 2007 · 89 · 123410.1016/j.biochi.2007.06.012 ↗